BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Treatment
11 results:

  • 1. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
    Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
    Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
    Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
    Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.
    Taylor AM; Sun JM; Yu A; Voicu H; Shen J; Barkauskas DA; Triche TJ; Gastier-Foster JM; Man TK; Lau CC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887382
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells.
    Özgür A
    J Chemother; 2021 Dec; 33(8):554-563. PubMed ID: 33794753
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of Osteonecrosis of the Jaw With Zoledronic Acid treatment for bone Metastases in Patients With cancer.
    Van Poznak CH; Unger JM; Darke AK; Moinpour C; Bagramian RA; Schubert MM; Hansen LK; Floyd JD; Dakhil SR; Lew DL; Wade JL; Fisch MJ; Henry NL; Hershman DL; Gralow J
    JAMA Oncol; 2021 Feb; 7(2):246-254. PubMed ID: 33331905
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Mutational Profile of Unicystic Ameloblastoma.
    Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
    J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
    Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
    Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Breast cancer genome-wide association studies: there is strength in numbers.
    Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
    Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and treatment of cancer study.
    Herbrecht R; Maertens J; Baila L; Aoun M; Heinz W; Martino R; Schwartz S; Ullmann AJ; Meert L; Paesmans M; Marchetti O; Akan H; Ameye L; Shivaprakash M; Viscoli C
    Bone Marrow Transplant; 2010 Jul; 45(7):1227-33. PubMed ID: 20062093
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.